-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.50296.83% Upside
TELA Bio, Inc. Frequently Asked Questions
-
What analysts cover TELA Bio, Inc.?
TELA Bio, Inc. has been rated by research analysts at Lake Street, Piper Sandler, Canaccord Genuity, JMP Securities in the past 90 days.